News
The new approach involves binding a copper chloride to a chiral phosphine ligand—one that ... The team demonstrated their catalyst using a variety of alkyl halides, and in all cases, they found it ...
Vertex Pharmaceuticals, 86-88 Jubilee Avenue, Milton Park, Abingdon OX14 4RW, U.K.
The new catalyst features a copper chloride unit bound to a bulky, chiral phosphine ligand that modulates its reactivity. When activated by light, the excited catalyst engages in a single electron ...
The protocol for the new reactions is strikingly simple: mix an alkyl halide with copper(i) chloride and a commercially available chiral ligand (an organic molecule that binds to the copper atoms ...
Center of Pharmaceutical Engineering (PVZ), Technische Universität Braunschweig, Franz-Liszt-Straße 35a, 38106 Braunschweig, Germany Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results